Scinai Immunotherapeutics Ltd. Annual Nonoperating Income (Expense) in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Scinai Immunotherapeutics Ltd. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2022.
  • Scinai Immunotherapeutics Ltd. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was -$1.17M, a 517% decline year-over-year.
  • Scinai Immunotherapeutics Ltd. annual Nonoperating Income (Expense) for 2022 was $5.27M, a 98.2% increase from 2021.
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $5.27M +$2.61M +98.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 $2.66M Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.